ABEO YTD Return
Start date: 12/31/2018
End date: 05/23/2019
Start price/share: $7.14
End price/share: $6.49
Dividends collected/share: $0.00
ABEO YTD return: -9.10%
Annualized Gain: -23.40%
Starting investment: $10,000.00
Ending investment: $9,090.00
Years: 0.39


ABEO YTD return is presented with the assumption of reinvestments of any dividends on ex-date.
Compare ABEO YTD return (see YTD Return Formula; YTD Return vs Yield) versus benchmarks:

YTD Return on S&P
YTD Return on Dow
YTD Return on Nasdaq 100
YTD Return on Russell 2000
YTD Return on Gold
YTD Return on 10 Year Treasury
YTD Return on $10,000.00
Without Dividends Reinvested Into ABEO

Abeona Therapeutics is a clinical-stage biopharmaceutical company developing cell and gene therapies for life-threatening rare genetic diseases. Co.'s main programs include EB-101 (gene-corrected skin grafts) for recessive dystrophic epidermolysis bullosa (RDEB), ABO-102 (AAV-SGSH), an adeno-associated virus (AAV) based gene therapy for Sanfilippo syndrome type A (MPS IIIA) and ABO-101 (AAV NAGLU), an AAV based gene therapy for Sanfilippo syndrome type B (MPS IIIB). Co. is also developing ABO-201 (AAV-CLN3) gene therapy for juvenile Batten disease (JNCL), and ABO-202 (AAV-CLN1) for treatment of infantile Batten disease (INCL), among others. The ABEO YTD return is shown above.

The YTD Return on the ABEO YTD return page and across the coverage universe of our site, is a measure of the total return for a given investment year-to-date for the current calendar year (up to the end of prior trading session). Arguably, choosing the current calendar year for a measurement period is on the one hand completely arbitrary, but on the other hand a year-to-date look can be extremely useful in the context of our country's tax system which taxes gains and income on a calendar year basis.

Thus, researching Year-To-Date Returns is good practice for investors — whether ABEO YTD return or other benchmarks/peers — and when doing so it is also important to factor in dividends, because a financial instrument's YTD return is more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors by performing the ABEO YTD return calculation (with any dividends reinvested as applicable), and to provide a coverage universe of many stocks and ETFs to be able to compare YTD returns.
Quotes delayed 20 minutes
Get Free SEC filing alerts for ABEO:
ABEO SEC Filing Email Alerts ServiceExternal link
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Don't Forget Dividends in YTD Return!


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Abeona Therapeutics (ABEO) is categorized under the Healthcare sector; to help you further research YTD return performance across stocks, below are some other companies in the same sector:

ABIO YTD Return
ABMD YTD Return
ABT YTD Return
ACAD YTD Return
ACER YTD Return
ACET YTD Return
ACHC YTD Return
ACHN YTD Return
ACHV YTD Return
ACOR YTD Return
More Healthcare companies »

 

ABEO YTD Return | www.YTDReturn.com | Copyright © 2017 - 2019, All Rights Reserved

Nothing in YTDReturn.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.